Related Experiment Video
Updated: Aug 11, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Sperm banking: is it a viable option for cancer patients?
Abstract:
Should cryopreservation be routinely offered to cancer patients undergoing therapy that could eventually cause gonadal damage, even if their semen is suboptimal? The possibilities for successful reproductive outcomes are encouraging for cancer patients whose complete loss of fertility would otherwise occur. Although many technical, legal, and ethical considerations remain, failure to appraise patients of reproductive options that are available to them is a violation of patient autonomy.
Insights
Cancer patients facing fertility loss due to therapy should be offered cryopreservation, even with suboptimal semen. Preserving reproductive options is crucial for patient autonomy and future family planning.
Area of Science:
- Reproductive medicine
- Oncology
- Bioethics
Background:
- Cancer therapies can cause irreversible gonadal damage, leading to infertility.
- Suboptimal semen parameters do not preclude future reproductive success.
- Patient autonomy necessitates informed consent regarding fertility preservation options.
Purpose of the Study:
- To evaluate the routine offering of cryopreservation to cancer patients with suboptimal semen.
- To discuss the implications of fertility preservation for cancer survivors.
- To highlight the ethical considerations surrounding reproductive options for cancer patients.
Main Methods:
- Review of current practices in fertility preservation for cancer patients.
- Analysis of reproductive outcomes following cryopreservation of suboptimal semen.
- Ethical and legal framework assessment for offering fertility preservation.
Main Results:
- Cryopreservation offers encouraging possibilities for reproductive outcomes in cancer patients.
- Failure to inform patients about available reproductive options violates their autonomy.
- Technical, legal, and ethical considerations require ongoing attention.
Conclusions:
- Cryopreservation should be routinely considered for cancer patients at risk of gonadal damage, irrespective of initial semen quality.
- Informed consent regarding fertility preservation is an ethical imperative.
- Further research and policy development are needed to address remaining challenges.
Related Concept Videos
Spermatogenesis
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Infertility in Males
Cancer Survival Analysis

